万维提示：
1、投稿方式：在线投稿。
2、刊内网址（202506期）：
http://www.zhhlzzs.com
https://www.journals.elsevier.com/international-journal-of-nursing-sciences
自动跳转至：
https://www.sciencedirect.com/journal/international-journal-of-nursing-sciences
3、投稿系统：https://submit.elsevier.com/IJNSS
4、刊内邮箱：cnaijns@163.com
5、刊内电话：010-53779541
6、出刊日期：双月刊，一年出版六期。
7、刊内微信公众号：中华护理杂志社（zhhlzzs）
2026年1月16日星期五
Guide for authors
【官网信息】
Introduction
Journal Announcements
Effective 8 December 2025, the journal has transitioned to a new submission platform: https://submit.elsevier.com/IJNSS. New submissions should be made via this platform. Manuscripts submitted before this date will continue to be managed in Editorial Manager (EM); please also submit any revisions through EM at https://www.editorialmanager.com/ijnss/default.aspx
International Journal of Nursing Sciences (IJNSS, Print ISSN 2096-6296, and Online ISSN 2352-0132, CN:10-1444/R) is the official peer-reviewed research journal of Chinese Nursing Association. This journal aims to promote excellence in nursing and health care through the dissemination of the latest, evidence-based, peer-reviewed clinical information and original research, providing an international platform for exchanging knowledge, research findings and nursing practice experience. IJNSS publishes four issues per year in Jan/Apr/Jul/Oct. IJNSS intended readership includes practicing nurses in all spheres and at all levels who are committed to advancing practice and professional development on the basis of new knowledge and evidence; managers and senior members of the nursing; nurse educators and nursing students etc. IJNSS seeks to enrich insight into clinical need and the implications for nursing intervention and models of service delivery. Contributions are welcomed from other health professions on issues that have a direct impact on nursing practice.
Types of article
The IJNSS publishes original research papers, reviews, discussion papers, editorial and letters to the editor.
Before you begin
Reporting Guidelines
The guidelines listed below should be followed where appropriate. Please use these guidelines to structure your article. Structured abstracts and flow diagrams should be uploaded with your submission; these will be published alongside the final version of your paper.
CONSORT (for reporting of randomized controlled trials: please use the appropriate extension to the CONSORT statement, including TIDieR checklist to better reporting of interventions)
STROBE (for reporting of observational cohort, case control and cross sectional studies)
PRISMA (for reporting of systematic reviews)
SRQR (for reporting of qualitative studies)
SQUIRE (for reporting of quality improvement studies, including SQUIRE-EDU for educational improvement)
CARE (for case report, including extensions for specific case report)
CHEERS (for reporting of health economic evaluations)
STARD (for reporting of diagnostic accuracy studies, including the TRIPOD statement for reporting of a multivariable prediction model for individual prognosis or diagnosis)
AGREE (for reporting of clinical practice guidelines)
The Equator Network
(http://www.equator-network.org/resource-centre/library-of-health-research-reporting/library/ ) provides a comprehensive list of reporting guidelines.
Ethical Approval
All studies must be conducted to a high ethical standard and must adhere to local regulations and standards for gaining scrutiny and approval.
The work described in your article must have been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans http://www.wma.net/en/30publications/10policies/b3/; EC Directive 86/609/EEC for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm. This must be stated at an appropriate point in the article.
For information on Ethics in Publishing and Ethical guidelines for journal publication see https://www.elsevier.com/authorethics.
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission. https://www.elsevier.com/authors/journal-authors/policies-and-ethics
Conflict of Interest
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See alsohttps://www.elsevier.com/conflictsofinterest. Further information and an example of a Conflict of Interest form can be found at:https://service.elsevier.com/app/answers/detail/a_id/286/supporthub/publishing.
The IJNSS use the ICMJE Form for Disclosure of Potential Conflicts of Interest to generate a disclosure statement for your manuscript. See also https://www.icmje.org/conflicts-of-interest/
Trial or other study registration
We encourage the prospective registration of studies. Where a study has been registered please give the number in the registration number within the title, abstract or body of the paper as appropriate.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see 'Multiple, redundant or concurrent publication' section of our ethics policy for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service CrossCheck.
Contributors and Acknowledgements
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
In the covering letter to the editorial office, we ask that roles for each and every author be individually described, with reference to the criteria for authorship. You must make a true statement that all authors have approved the final article and acknowledge that all those entitled to authorship are listed as authors.
Those who meet some but not all of the criteria for authors can be identified as 'contributors' at the end of the manuscript with their contribution specified. All those individuals who provided help during the research (e.g., collecting data, providing language help, writing assistance or proofreading the article, etc.) that do not meet criteria for authorship should be acknowledged in the paper.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright, see https://www.elsevier.com/about/company-information/policies/copyright). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.
For open access articles: Upon acceptance of an article, authors will be asked to complete an 'Exclusive License Agreement' (for more information see https://www.elsevier.com/OAauthoragreement). Permitted third party reuse of open access articles is determined by the author's choice of user license (seehttps://www.elsevier.com/openaccesslicenses).
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. For more information see https://www.elsevier.com/about/company-information/policies/copyright.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals on https://www.elsevier.com/authors/journal-authors/submit-your-paper/sharing-and-promoting-your-article
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
If you received no external funding (i.e. other than your main employer) please state 'no external funding'.
Funding body agreements and policies
Elsevier has established a number of agreements with funding bodies which allow authors to comply with their funder's open access policies. Some funding bodies will reimburse the author for the Open Access Publication Fee. Details of existing agreements are available online.
After acceptance, open access papers will be published under a noncommercial license. For authors requiring a commercial CC BY license, you can apply after your manuscript is accepted for publication.
Open access
Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication. To provide open access, the authors (or funders and institutes) will be charged an article processing charge (APC) of 150 USD per page (excluding taxes).
A CC user license manages the reuse of the article (see https://www.elsevier.com/openaccesslicenses). All articles will be published under the following license:
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.
Please visit our Open Access page for more information about open access publishing in this journal.
Elsevier’s Researcher Academy
If you would like help to improve your submission or navigate the publication process, support is available via “Researcher Academy.”
Researcher Academy offers free e-learning modules, webinars, downloadable guides and research writing and peer review process resources.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop.
Submission
Submit online
Our online submission system guides you through the process steps of entering your manuscript details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process.
Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the editor's decision and requests for revision, is sent by email.
Please submit via https://submit.elsevier.com/IJNSS
Peer review
This journal operates a double blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. More information on types of peer review.
Authors may choose to submit the names and institutional e-mail addresses of three potential referees. Note that the editor retains the sole right to decide whether or not the suggested reviewers are used.
Declaration of generative AI in scientific writing
Authors must declare the use of generative AI in the manuscript preparation process upon submission of the paper.
Elsevier recognizes the potential of generative AI and AI-assisted technologies (“AI Tools”), when used responsibly, to help researchers work efficiently, gain critical insights fast and achieve better outcomes. Increasingly, these tools, including AI agents and deep research tools, are helping researchers to synthesize complex literature, provide an overview of a field or research question, identify research gaps, generate ideas, and provide tailored support for tasks such as content organization and improving language and readability.
Authors preparing a manuscript for an Elsevier journal can use AI Tools to support them. However, these tools must never be used as a substitute for human critical thinking, expertise and evaluation. AI technology should always be applied with human oversight and control.
Ultimately, authors are responsible and accountable for the contents of their work. This includes accountability for:
Carefully reviewing and verifying the accuracy, comprehensiveness, and impartiality of all AI-generated output (including checking the sources, as AI-generated references can be incorrect or fabricated).
Editing and adapting all material thoroughly to ensure the manuscript represents the author’s authentic and original contribution and reflects their own analysis, interpretation, insights and ideas.
Ensuring the use of any tools or sources, AI-based or otherwise, is made clear and transparent to readers. If AI Tools have been used, we require a disclosure statement upon submission; please see example below.
Ensuring the manuscript is developed in a way that safeguards data privacy, intellectual property and other rights, by checking the terms and conditions of any AI tool that is used.
Finally, authors must not list or cite AI Tools as an author or co-author on the manuscript since authorship implies responsibilities and tasks that can only be attributed to, and performed by, humans.
The use of AI Tools in the manuscript preparation process must be declared by adding a statement at the end of the manuscript when the paper is first submitted. The statement will appear in the published work and should be placed in a new section before the references list.
......
更多详见：
https://www.sciencedirect.com/journal/international-journal-of-nursing-sciences/publish/guide-for-authors
